80
Participants
Start Date
January 8, 2024
Primary Completion Date
December 17, 2024
Study Completion Date
December 27, 2024
Hormone-free vulvovaginal gel with tested composition XCM® INTIM and PROMs questionnaire.
"Management of GSM in post-menopausal women will be measured with the combination of the application of the hormone-free vulvovaginal gel along the 8 weeks of the study and the use of a PROMs questionnaire. PROMS questionnaire will be delivered to the women at baseline and at the end of the study. Daily living quality of life domains of activities of daily living, emotional well-being, sexual functioning, self-perception and body image will be evaluated."
Mucosa Innovations S.L., Madrid
Lead Sponsor
Hospital de La Luz
OTHER
Hospital Universitario Fundación Jiménez Díaz
OTHER
Mucosa Innovations, S.L.
INDUSTRY